Barriers to HPV vaccine introduction and revitalization in sub-Saharan francophone African countries – A qualitative descriptive study

The pace of progress of HPV vaccine introduction in Sub-Saharan francophone African countries has been limited, particularly in conflict-affected countries. To better understand the barriers affecting the introduction and sustainability of the HPV vaccine, we conducted a qualitative study from January – April 2024 informed by insights from a multi-country HPV symposium. Our study explored […]

Status of HPV disease and vaccination programmes in LMICs: Introduction to special issue

In this introduction to the special issue, Borda and colleagues present an overview of the current global epidemiology of cervical cancer incidence and mortality, with the highest burden concentrated in Africa and Asia. The article highlights decreased HPV vaccination coverage in recent years and underlines the need for new vaccine introductions and programme strengthening to […]

CHIC: Coalition to Strengthen the HPV Immunization Community – Briefing on HPV and Vaccination

This CHIC briefing document provides a concise overview of HPV disease burden, vaccination programmes, and key challenges facing low- and middle-income countries. It describes HPV as the most common sexually transmitted infection globally, responsible for over 630,000 new cancer cases and 311,000 deaths annually, with 530,000 being cervical cancers. The brief highlights that over 85% […]

HPV Vaccination Programs in LMICs from Asia & Western Pacific Regions Symposium – Report

This report summarizes the fourth CHIC symposium, held in Manila, Philippines (October 2–4, 2024), bringing together 95 participants from 17 countries across the Asia and Western Pacific regions. Participants included civil society organizations, Ministries of Health and Education, NGOs, NITAG members, EPI managers, and key global partners including WHO, UNICEF, Gavi, JSI, and PATH. The […]

>